Get the app!
Back to Trades

Carter Robert Ross

Chief Financial OfficerCIK 0002039341

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
5
Buy transactions
0
Sell transactions
1
Companies
1
Active
2025–2026

Across 5 filings between 2025–2026, Carter Robert Ross, Chief Financial Officer, has disclosed $70.9K in transactions — all concentrated in Starling Oncology, Inc. (STLN). Their disclosed trades are heavily weighted toward selling — $0 in buys and $879 in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

5 loaded
Nov 19STLN
Starling Oncology, Inc.
Carter Robert RossChief Financial OfficerOther$469
May 22TOI
Oncology Institute, Inc.
Carter Robert RossChief Financial OfficerOther$7.2K
Apr 1TOI
Oncology Institute, Inc.
Carter Robert RossChief Financial OfficerGrant$62.4K
Jan 5TOI
Oncology Institute, Inc.
Carter Robert RossChief Financial OfficerSell$879
Nov 19TOI
Oncology Institute, Inc.
Carter Robert RossChief Financial OfficerGrant$0

5 filings